A new tool named T1GRS enables researchers to get more accurate, further-reaching risk scores for the greater population ...
DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee ™ a new, AI-powered ...
MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Artificial intelligence and predictive analytics are advancing diabetes prevention, diagnosis, and management by integrating data from continuous glucose monitors, electronic health records, and other ...